Please login to the form below

Not currently logged in
Email:
Password:

Gocovri

This page shows the latest Gocovri news and features for those working in and with pharma, biotech and healthcare.

FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease

FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease

In two phase 3 clinical studies, Gocovri treatment was shown to significantly reduce both OFF time and dyskinesia. ... Gocovri is now the first and only medication approved to treat both OFF and dyskinesia motor complications in Parkinson’s disease,”

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...